A pilot clinical study of oral irinotecan HCl (VAL-413) in patients with recurrent pediatric solid tumors

被引：0

作者：

Bacha, Jeffrey A.

Brown, Dennis

Geller, James I.

Oesterheld, Javier E.

McManus, Meghann

Kanekal, Sarath

Leggas, Markos

Lopez, Lorena

Sankar, Neil

Yam, Noymi

Wagner, Lars M.

机构：

[1] Edison Oncol Holding Corp, Menlo Pk, CA USA

[2] Valent Technol LLC, Menlo Pk, CA USA

[3] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA

[4] Levine Childrens Hosp, Charlotte, NC USA

[5] Sarah Cannon Res Hosp HCA, Nashville, TN USA

[6] St Jude Childrens Res Hosp, Memphis, TN USA

[7] Univ Memphis, Memphis, TN USA

[8] Duke Univ, Durham, NC USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS10073

引用

页数：1

共 50 条

[31] Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors
Lee, J. W.
Lee, B.
Shim, J. H.
Joung, J. G.
Koo, H. H.
Sung, K. W.
Park, W. Y.
Kook, H.
Jung, H. L.
PEDIATRIC BLOOD & CANCER, 2018, 65 : S646 - S647
[32] A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors
Pearson, Andrew D. J.
Federico, Sara M.
Aerts, Isabelle
Hargrave, Darren R.
DuBois, Steven G.
Iannone, Robert
Geschwindt, Ryan D.
Wang, Ruixue
Haluska, Frank G.
Trippett, Tanya M.
Geoerger, Birgit
ONCOTARGET, 2016, 7 (51): : 84736 - 84747
[33] Modulation of 5-fluorouracil by irinotecan in advanced solid tumors - a pilot study
Creaven, PJ
Slocum, HK
Toth, K
Pendyala, L
Smith, P
Litwin, A
Intengan, M
Javle, MM
Ramnath, N
Loewen, G
Rustum, YM
INTERNATIONAL JOURNAL OF CANCER, 2002, : 94 - 94
[34] A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors
Venkatramani, Rajkumar
Malogolowkin, Marcio
Davidson, Tom B.
May, William
Sposto, Richard
Mascarenhas, Leo
PLOS ONE, 2013, 8 (07):
[35] Topotecan in pediatric patients with recurrent and progressive solid tumors: A pediatric oncology group phase II study
Nitschke, R
Parkhurst, J
Sullivan, J
Harris, MB
Bernstein, M
Pratt, C
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (04) : 315 - 318
[36] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
Allegrini, Giacomo
Di Paolo, Antonello
Cerri, Elisa
Cupini, Samanta
Amatori, Federica
Masi, Gianluca
Danesi, Romano
Marcucci, Lorenzo
Bocci, Guido
Del Tacca, Mario
Falcone, Alfredo
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) : 585 - 593
[37] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
Giacomo Allegrini
Antonello Di Paolo
Elisa Cerri
Samanta Cupini
Federica Amatori
Gianluca Masi
Romano Danesi
Lorenzo Marcucci
Guido Bocci
Mario Del Tacca
Alfredo Falcone
Cancer Chemotherapy and Pharmacology, 2006, 58 : 585 - 593
[38] A pilot clinical study of apatinib plus irinotecan in patients with recurrent high-grade glioma Clinical Trial/Experimental Study
Wang, Lei
Liang, Lijun
Yang, Tao
Qiao, Yun
Xia, Youyou
Liu, Liang
Li, Chao
Lu, Peizhi
Jiang, Xiaodong
MEDICINE, 2017, 96 (49)
[39] Phase 1 Study of an Oxaliplatin and Etoposide Regimen in Pediatric Patients With Recurrent Solid Tumors
McGregor, Lisa M.
Spunt, Sheri L.
Santana, Victor M.
Stewart, Clinton F.
Ward, Deborah A.
Watkins, Amy
Laningham, Fred H.
Ivy, Percy
Furman, Wayne L.
Fouladi, Maryam
CANCER, 2009, 115 (03) : 655 - 664
[40] Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
Morgenstern, Daniel A.
Marzouki, Monia
Bartels, Ute
Irwin, Meredith S.
Sholler, Giselle L. S.
Gammon, Janet
Yankanah, Rosanna
Wu, Bing
Samson, Yvan
Baruchel, Sylvain
PEDIATRIC BLOOD & CANCER, 2014, 61 (01) : 128 - 133

← 1 2 3 4 5 →